Home
>
National Drug Code (NDC)
>
Ortho Evra
Ortho Evra - 50458-192-01 - (norelgestromin and ethinyl estradiol)
Drug Information of Ortho Evra
| Product NDC: | 50458-192 |
| Proprietary Name: | Ortho Evra |
| Non Proprietary Name: | norelgestromin and ethinyl estradiol |
| Active Ingredient(s): | .75; 6 mg/7d; mg/7d & nbsp; norelgestromin and ethinyl estradiol |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ortho Evra
| Product NDC: | 50458-192 |
| Labeler Name: | Janssen Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021180 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20011120 |
Package Information of Ortho Evra
| Package NDC: | 50458-192-01 |
| Package Description: | 7 d in 1 PATCH (50458-192-01) |
NDC Information of Ortho Evra
| NDC Code | 50458-192-01 |
| Proprietary Name | Ortho Evra |
| Package Description | 7 d in 1 PATCH (50458-192-01) |
| Product NDC | 50458-192 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | norelgestromin and ethinyl estradiol |
| Dosage Form Name | PATCH, EXTENDED RELEASE |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 20011120 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceutical, Inc. |
| Substance Name | ETHINYL ESTRADIOL; NORELGESTROMIN |
| Strength Number | .75; 6 |
| Strength Unit | mg/7d; mg/7d |
| Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |
